COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR

Abstract Background Colorectal cancer is a public health issue and was the third leading cause of cancer-related death worldwide in 2022. Early diagnosis can improve prognosis, making screening a central part of colorectal cancer management. Blood-based screening, diagnosis and follow-up of colorect...

Descrición completa

Detalles Bibliográficos

Principais autores:	Alexis Overs, Paul Peixoto, Eric Hervouet, Chloé Molimard, Franck Monnien, Jules Durand, Michael Guittaut, Angélique Vienot, Julien Viot, Michael Herfs, Christophe Borg, Jean-Paul Feugeas, Zohair Selmani
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-10-01
Series:	Clinical Epigenetics
Assuntos:	COL25A1 METAP1D DNA methylation Liquid biopsy Circulating tumor DNA Biomarker
Acceso en liña:	https://doi.org/10.1186/s13148-024-01748-1
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!